SciSparc Change in Assets/Liabilities 2017-2024 | SPRC

SciSparc change in assets/liabilities from 2017 to 2024. Change in assets/liabilities can be defined as represents any other changes in assets/liabilities

SciSparc Change in Assets/Liabilities 2017-2024 | SPRC

SciSparc change in assets/liabilities from 2017 to 2024. Change in assets/liabilities can be defined as represents any other changes in assets/liabilities
Related Stocks
Company NameMarket
Cap
Chugai Pharmaceutical (CHGCY)$66B
Zoetis (ZTS)$65.7B
Daiichi Sankyo, - (DSNKY)$46.5B
Takeda Pharmaceutical (TAK)$45.7B
BeOne Medicines - (ONC)$32.7B
Sandoz Group AG (SDZNY)$27.5B
Summit Therapeutics (SMMT)$20.8B
Merck (MKKGY)$15.9B
Shionogi (SGIOY)$15.1B
United Therapeutics (UTHR)$13.5B
Neurocrine Biosciences (NBIX)$12.5B
IPSEN (IPSEY)$10.4B
Orion OYJ (ORINY)$10.3B
Madrigal Pharmaceuticals (MDGL)$7.6B
Corcept Therapeutics (CORT)$7.5B
Stevanato Group S.p.A (STVN)$7.3B
Grifols, S.A (GRFS)$7.3B
Ionis Pharmaceuticals (IONS)$6.5B
Hikma Pharmaceuticals Plc (HKMPF)$5.9B
Ono Pharmaceutical (OPHLF)$5.2B
Soleno Therapeutics (SLNO)$4.2B
Hypermarcas (HYPMY)$2.7B
Crinetics Pharmaceuticals (CRNX)$2.6B
NewAmsterdam Pharma (NAMS)$2.6B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.6B
Catalyst Pharmaceuticals (CPRX)$2.4B
Centessa Pharmaceuticals (CNTA)$2.3B
Ocular Therapeutix (OCUL)$2.1B
Endo (NDOI)$1.8B
BioCryst Pharmaceuticals (BCRX)$1.8B